Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 8 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of SGF200 on Immune Enhancement

NCT04930640 is registered in ClinicalTrials.gov with Chonbuk National University Hospital as lead sponsor.

NCT NCT04930640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04930640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 8 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of SGF200 on Immune Enhancement
Lead sponsor
Chonbuk National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 25, 2021
Completion date
May 26, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunity